share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Dmytruk Mark E.

SEC announcement ·  Jan 5 13:00
Summary by Futu AI
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], engaged in a series of stock transactions beginning on January 2, 2024. Dmytruk acquired a total of 85,048 shares of Ginkgo Bioworks' Class A Common Stock through the exercise of derivative securities. The following day, on January 3, 2024, he sold 45,794 shares in an open market transaction at a price of $1.54 per share, resulting in a total sale value of $70,522.76. After these transactions, Dmytruk's direct holdings in the company amounted to 716,098 shares. The transactions have been reported as completed.
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], engaged in a series of stock transactions beginning on January 2, 2024. Dmytruk acquired a total of 85,048 shares of Ginkgo Bioworks' Class A Common Stock through the exercise of derivative securities. The following day, on January 3, 2024, he sold 45,794 shares in an open market transaction at a price of $1.54 per share, resulting in a total sale value of $70,522.76. After these transactions, Dmytruk's direct holdings in the company amounted to 716,098 shares. The transactions have been reported as completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.